Episode 33: Are We Testing for Hymenoptera Backwards?

allergytalk - Een podcast door allergytalk

Categorieën:

Welcome to Season Two of Allergytalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue! Today we joined by Dr. Vivan Hernandez-Trujillo, MD from Nicklaus Children’s Hospital in Miami, Florida where we review the July-Aug 2022 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.  You can also earn CME credit by listening to this podcast! For information about CME credit or to read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles! Articles Reviewed: Combining Discordant Serum IgE and Skin Testing Improves Diagnostic and Therapeutic Accuracy for Hymenoptera Venom Hypersensitivity Immunotherapy. Safety of Live Attenuated Influenza Vaccine in Children With Asthma. Obesity alters pathology and treatment response in inflammatory disease.   Please rate our podcast on iTunes! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.   Today’s speakers have the following disclosures: Dr. Lee has nothing to disclose Dr. Hernandez-Trujillo:  Speaker Takeda, CSL Advisory boards Takeda, Regeneron, Sanofi Consultant  Kaleo, Pharming, Enzyvant, National Peanut Board, Allergy and Asthma Network Dr. Fineman: Speaker: Takeda; Research: Aimmune, DBV, Biocryst

Visit the podcast's native language site